Type I interferon regulation of natural killer cell function in primary and secondary infections. (Q38132264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Type I interferon regulation of natural killer cell function in primary and secondary infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Michele L Stackaruk

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Amanda J Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

875-884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Human natural killer cell deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Human natural killer cell deficiencies and susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

A new self: MHC-class-I-independent natural-killer-cell self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Cytokine-induced memory-like natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Cancer immunotherapy: the interferon-alpha experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Functional role of type I and type II interferons in antiviral defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Persistent LCMV infection is controlled by blockade of type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Functionally distinct NK-cell subsets: developmental origins and biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Genital HSV-2 infection induces short-term NK cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Adaptive immune features of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Adjuvant activity of interferon alpha: mechanism(s) of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

The Canarypox-virus vaccine vector ALVAC triggers the release of IFN-gamma by Natural Killer (NK) cells enhancing Th1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

NK cell enhancement of antigen presentation by B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

DC therapy induces long-term NK reactivity to tumors via host DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Proinflammatory cytokine signaling required for the generation of natural killer cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Natural killer cells in infection and inflammation of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Differential Responses of Immune Cells to Type I Interferon Contribute to Host Resistance to Viral Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814871

10.1586/14760584.2013.814871

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23984959%20AND%20SRC:MED&resulttype=core&format=json

release_co7jbmj2ingqxmutxbvlvbkehm

8 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/co7jbmj2ingqxmutxbvlvbkehm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference